McMaster University
Elucidating The Epitope Recognized By A Recombinant Anti-Grp78 Antibody (Rab) That Causes Robust Tumour Regression In The Presence Of Anti-Grp78 Autoantibodies
Abstract
dc:description.abstractProstate cancer is a life-threatening disease that is nearly impossible to treat once it spreads. A protein called GRP78, which normally resides inside cells, can appear on the surface of prostate cancer cells. When it does, it causes patients to make autoantibodies (AutoAb) to surface GRP78 that unexpectedly help the cancer to grow. For my MSc research project, I studied a recombinant antibody (rAb) against GRP78 that markedly causes tumour regression only in the presence of the GRP78 AutoAb. However, the location where this rAb binds to GRP78 has not been identified. As a first approach to map the rAb binding site on GRP78, I generated different recombinant protein fragments that spanned the GRP78 protein and tested their ability to bind them using an established ELISA assay. My initial efforts identified a region in the C-terminus of GRP78 that had the ability of binding the rAb. To identify the exact location of the rAb binding domain, a peptide library containing overlapping 8-13 amino acid peptides of GRP78 was screened. I found that the rAb targets a specific domain encoding a region of GRP78. Knowing this exact region is an important step toward creating new therapies for patients with advanced prostate cancer.
Degree
thesis:*- Department dc:contributor.department
- Health Sciences
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Thangarajah, Rishi
- Advisor dc:contributor.advisor
-
- Austin, Richard
Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.71548/8141